Browsing Category

Top Industry News

7462 posts

Novartis Details Plans for Major Manufacturing Expansion in North Carolina
By

By
Novartis has announced plans to expand its operations in North Carolina by creating a new manufacturing hub with drug-substance and drug-product capabilities. The investment is part of the company’s previously…

Regeneron To Invest $2 Bn in US Drug Mfg 
By

By
Regeneron Pharmaceuticals, a Tarrytown, New York-based bio/pharmaceutical company, has announced plans to invest $2 billion for a new manufacturing facility in Saratoga Springs, New York.   The company plans to use…

CSL Investing $1.5 Bn in US Plasma-Derived Product Production
By

By
CSL has announced plans to expand its US presence over the next five years (as reported on November 18, 2025) resulting in approximately $1.5 billion in US capital investments. These…

Merck & Co. To Acquire Cidara Therapeutics for $9.2 Bn
By

By
Merck & Co. has agreed to acquire Cidara Therapeutics, a San Diego, California-based clinical-stage bio/pharmaceutical company developing drug-Fc conjugate therapeutics, for $9.2 billion.  Cidara is using its proprietary Cloudbreak platform…

Supplier News: Thermo Fisher, Avantor, BioDuro, Gattefossé, Pace & More
By

By
The latest from CDMOs, CMOs, and suppliers featuring Thermo Fisher Scientific, Avantor, BioDuro, Gattefossé, Nanoform, and Pace Life Sciences. Biologics Manufacturing* Thermo Fisher Scientific Opens Advanced Therapies Collaboration CenterFormulation Development/Drug…

Global Briefs: Moderna, J&J, Alkermes, Lilly, Teva & Halozyme
By

By
A roundup of news from Moderna, J&J/Halda, Alkermes/Avadel, Halozyme/Elektrofi, Lilly, and Teva Pharmaceutical. Highlights below. Manufacturing News*Moderna Onshoring Drug-Product Mfg for mRNA Medicines to USM&A News* J&J To Acquire Halda…

Pfizer Wins Bidding War for Obesity Drug Specialist Metsera
By

By
Pfizer has won its bidding war with Novo Nordisk for Metsera, a New York-based clinical-stage bio/pharmaceutical company focused on obesity and cardiometabolic diseases, with a successful offer, worth up to…

FDA Names New Head of CDER 
By

By
Richard Pazdur, M.D., currently Director of the Oncology Center of Excellence at the US Food and Drug Administration (FDA), has been named the new Director of the Center of Drug…

Novartis Opens New Radioligand Therapy Mfg Facility in the US 
By

By
Novartis has opened a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in Carlsbad, California. The facility is part of the company’s previously announced planned $23-billion investment over five years in…

Mallinckrodt, Endo Launch as Keenova Therapeutics Following Merger Close; Spin Off Par Health 
By

By
Mallinckrodt and Endo, two specialty pharma and generics companies, have announced the next step in their merger plan, first announced in March 2025, and completed on August 1, 2025. The…